Dibucaine Topical application and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Dibucaine Topical application and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dibucaine topical
Brand name: Dibucaine, Nupercainal, Rectacaine
Synonyms: Dibucaine topical, Dibucaine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dibucaine Topical application-Insulin degludec
- Dibucaine Topical application-Insulin Degludec (U-100) Prefilled Pens
- Dibucaine Topical application-Insulin Degludec (U-100) Vials
- Dibucaine Topical application-Insulin Degludec (U-200) Prefilled Pens
- Dibucaine Topical application-Insulin degludec and liraglutide
- Dibucaine Topical application-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dicel
- Insulin aspart, recombinant Subcutaneous-Dichlorphenamide
- Insulin aspart, recombinant Subcutaneous-Diclegis
- Insulin aspart, recombinant Subcutaneous-Diclo Gel
- Insulin aspart, recombinant Subcutaneous-Diclo Gel with Xrylix
- Insulin aspart, recombinant Subcutaneous-Diclofenac